Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum Kane Biotech Inc KNBIF

Primary Symbol: V.KNE

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired... see more

Add To Watchlist

Bullboard (TSXV:KNE)

View:

Comment by francoisl13on Sep 11, 2024 2:26pm

RE:New hire...

Here's some info from LinkedIN; Marie-Pierre Maltais Relation de 3e niveau Canadian Business Development Manager - Kane Biotech Inc. Marie-Pierre ...more

Discussion

Comment by francoisl13on Sep 11, 2024 2:20pm

RE:RE:RE:RE:Technical analysis

I understand KevinOleary. FDA dealys are common but it's been happening with the almost every aspects of their business in the past -- for example, look at the acne trial with UofMiami...it's ...more

Discussion

Lahontan Gold Announces Filing of Santa Fe Technical Report

posted Nov 29, 2024 9:00am by Lahontan Gold Corp.

Lahontan Gold is pleased to announce that the Company has filed on SEDAR+ an independent Technical Report and updated Mineral Resource Estimate ("MRE") titled "Santa Fe Project Technical Report," effective October 9, 2024, and dated November 27, 2024, for Lahontan's Santa Fe Mine gold and silver project, Santa Fe District, Mineral County, Nevada. ...read more

Post by francoisl13on Sep 11, 2024 2:13pm

New hire...

KNE just hired a Sales Director for Canada...saw that on LinkedIN. She doesn't have much expertise in sales based on her LinkedIN page but, let's give her some times and wil see by ourself ...more

Discussion

Comment by KevinOlearyon Sep 11, 2024 1:40pm

RE:RE:RE:Technical analysis

Their timelines are controlled by the FDA. FDA does not understand biofilms, so they keep wasting time asking questions. No one can tell when the FDA will make decisions, and you can't just call ...more

Discussion

Comment by francoisl13on Sep 11, 2024 1:08pm

RE:RE:Technical analysis

I'm using TA for entry and exit points, it seems to work for me for that very specific purposes. I agree that doing our DD and following closely what a company does is more important especially ...more

Discussion

Comment by KevinOlearyon Sep 11, 2024 1:00pm

RE:Technical analysis

TA is a useless summary of yesterday's trading statistics which are useless counts of how many shares traded and how many times sellers and buyers made a trade etc. I have never used TA. People ...more

Discussion

Post by francoisl13on Sep 11, 2024 9:45am

Technical analysis

To see this story with a different angle, let's look at a the technical analysis -- I know, I know it is believed not to be very accurate for micro-cap companies but considering the fact that ...more

Discussion

Comment by KevinOlearyon Aug 30, 2024 11:36pm

RE:RE:RE:RE:RE:RE:RE:Cash available vs expenses

Marc bought at $.15 last month so we should be good.

Discussion

Comment by francoisl13on Aug 30, 2024 9:45pm

RE:RE:RE:RE:RE:RE:Cash available vs expenses

Interesting comment. Thanks for taking the time to share your point of view.

Discussion

Comment by KevinOlearyon Aug 30, 2024 8:24pm

RE:RE:RE:RE:RE:Cash available vs expenses

There are too many things going on for me to have a clue what their short term cash needs will be. They have done lots of financings, so they know not to leave it to the last minute which makes me ...more

Discussion

Comment by francoisl13on Aug 30, 2024 4:01pm

RE:RE:RE:RE:Cash available vs expenses

@kevinOleary -- Despite the fact that they've been able to clean their balance sheet, are you not a little worry about KNE's financial situation considering the rate at which they spend money ...more

Discussion

Comment by francoisl13on Aug 30, 2024 3:57pm

RE:RE:RE:RE:Cash available vs expenses

Make sense. Then, it means that KNE will pay for this trial. This is getting me back to my original point that if they don't control their expenses better going forward they will likely have to ...more

Discussion

Comment by KevinOlearyon Aug 30, 2024 3:25pm

RE:RE:RE:Cash available vs expenses

If dispersin came from uni research they would have the ip and take a royalty. That's why kne has to pay a royalty to the guy who licensed it to them. U of M aren't going to get any future ...more

Discussion

Comment by francoisl13on Aug 30, 2024 2:50pm

RE:RE:Cash available vs expenses

I wonder if university have budget to do this? If so, they might do it and ask for some sort of payback based on future sales or something -- I'm not familair with how universities research is ...more

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Kane Biotech Inc KNBIF

Primary Symbol: V.KNE

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (TSXV:KNE)